Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults ≥ 55 Years Old. A Study Protocol for a Double-Blinded Randomized Controlled Clinical Trial

被引:5
作者
Avgerinos, K., I [1 ]
Mullins, R. J. [1 ]
Egan, J. M. [1 ]
Kapogiannis, D. [1 ]
机构
[1] NIA, NIH, Lab Clin Invest, 251 Bayview Blvd,8C228, Baltimore, MD 21224 USA
来源
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE | 2022年 / 9卷 / 01期
关键词
Ketosis; ketone ester; metabolic syndrome; Alzheimer's disease; magnetic resonance spectroscopy; cognition; extracellular vesicles; ALZHEIMERS-DISEASE; MOUSE MODEL; GLUCOSE-METABOLISM; SPECTROSCOPY; EXOSOMES; MILD; ABNORMALITIES; PROTEINS; CHILDREN; EFFICACY;
D O I
10.14283/jpad.2022.3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Ketone bodies have been proposed as an "energy rescue" for the Alzheimer's disease (AD) brain, which underutilizes glucose. Prior research has shown that oral ketone monoester (KME) safely induces robust ketosis in humans and has demonstrated cognitive-enhancing and pathology-reducing properties in animal models of AD. However, human evidence that KME may enhance brain ketone metabolism, improve cognitive performance and engage AD pathogenic cascades is scarce. Objectives To investigate the effects of ketone monoester (KME) on brain metabolism, cognitive performance and AD pathogenic cascades in cognitively normal older adults with metabolic syndrome and therefore at higher risk for AD. DESIGN: Double-blinded randomized placebo-controlled clinical trial. Setting Clinical Unit of the National Institute on Aging, Baltimore, US. Participants Fifty cognitively intact adults >= 55 years old, with metabolic syndrome. Intervention Drinks containing 25 g of KME or isocaloric placebo consumed three times daily for 28 days. Outcomes Primary: concentration of beta-hydroxybutyrate (BHB) in precuneus measured with Magnetic Resonance Spectroscopy (MRS). Exploratory: plasma and urine BHB, multiple brain and muscle metabolites detected with MRS, cognition assessed with the PACC and NIH toolbox, biomarkers of AD and metabolic mediators in plasma extracellular vesicles, and stool microbiome. Discussion This is the first study to investigate the AD-biomarker and cognitive effects of KME in humans. Ketone monoester is safe, tolerable, induces robust ketosis, and animal studies indicate that it can modify AD pathology. By conducting a study of KME in a population at risk for AD, we hope to bridge the existing gap between pre-clinical evidence and the potential for brain-metabolic, pro-cognitive, and anti-Alzheimer's effects in humans.
引用
收藏
页码:54 / 66
页数:13
相关论文
共 77 条
  • [1] Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. DIABETIC MEDICINE, 2006, 23 (05) : 469 - 480
  • [2] Mitochondrial function in vivo: Spectroscopy provides window on cellular energetics
    Amara, Catherine E.
    Marcinek, David J.
    Shankland, Eric G.
    Schenkman, Kenneth A.
    Arakaki, Lorilee S. L.
    Conley, Kevin E.
    [J]. METHODS, 2008, 46 (04) : 312 - 318
  • [3] Guidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity - a consensus of the Biomarkers Task Force from the WFSBP
    Andreazza, Ana C.
    Laksono, Isabelle
    Fernandes, Brisa S.
    Toben, Catherine
    Lewczuk, Piotr
    Riederer, Peter
    Kennedy, Sidney H.
    Kapogiannis, Dimitrios
    Thibaut, Florence
    Gerlach, Manfred
    Gallo, Carla
    Kim, Yong-Ku
    Grunblatt, Edna
    Yatham, Lakshmi
    Berk, Michael
    Baune, Bernhard T.
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2019, 20 (05) : 340 - 351
  • [4] Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease A Secondary Analysis of the Exenatide-PD Trial
    Athauda, Dilan
    Gulyani, Seema
    Karnati, Hanuma Kumar
    Li, Yazhou
    Tweedie, David
    Mustapic, Maja
    Chawla, Sahil
    Chowdhury, Kashfia
    Skene, Simon S.
    Greig, Nigel H.
    Kapogiannis, Dimitrios
    Foltynie, Thomas
    [J]. JAMA NEUROLOGY, 2019, 76 (04) : 420 - 429
  • [5] Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies
    Avgerinos, Konstantinos I.
    Egan, Josephine M.
    Mattson, Mark P.
    Kapogiannis, Dimitrios
    [J]. AGEING RESEARCH REVIEWS, 2020, 58
  • [6] Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes
    Baker, Laura D.
    Cross, Donna J.
    Minoshima, Satoshi
    Belongia, Dana
    Watson, Stennis
    Craft, Suzanne
    [J]. ARCHIVES OF NEUROLOGY, 2011, 68 (01) : 51 - 57
  • [7] A ketogenic diet improves motor performance but does not affect β-amyloid levels in a mouse model of Alzheimer's Disease
    Beckett, Tina L.
    Studzinski, Christa M.
    Keller, Jeffrey N.
    Murphy, M. Paul
    Niedowicz, Dana M.
    [J]. BRAIN RESEARCH, 2013, 1505 : 61 - 67
  • [8] EFFICACY OF APPLIED RELAXATION AND COGNITIVE-BEHAVIORAL THERAPY IN THE TREATMENT OF GENERALIZED ANXIETY DISORDER
    BORKOVEC, TD
    COSTELLO, E
    [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1993, 61 (04) : 611 - 619
  • [9] Ketogenic Diet Improves Motor Performance but Not Cognition in Two Mouse Models of Alzheimer's Pathology
    Brownlow, Milene L.
    Benner, Leif
    D'Agostino, Dominic
    Gordon, Marcia N.
    Morgan, Dave
    [J]. PLOS ONE, 2013, 8 (09):
  • [10] Fuel metabolism in starvation
    Cahill, George F., Jr.
    [J]. ANNUAL REVIEW OF NUTRITION, 2006, 26 : 1 - 22